Concept Medical Announces Successful Completion of Patient Enrollment in Landmark SirPAD Trial for Peripheral Arterial Disease Treatment

CMI, a global leader in innovative drug delivery technologies for vascular procedures, is proud to announce that patient enrollment in the SirPAD trial has...

January 21, 2025 | Tuesday | News
Novo Nordisk Announces Positive Results from STEP UP Phase 3b Trial for Semaglutide 7.2 mg in Obesity Treatment

Novo Nordisk  announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial i...

January 20, 2025 | Monday | News
Fermion and Simcere Partner to Advance Innovative SSTR4 Agonist for Pain Management in Greater China

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain ...

January 20, 2025 | Monday | News
UCSF and GE HealthCare Launch Care Innovation Hub to Advance Medical Imaging and Treatment

University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE HealthCare  announced the launch of a Care Inno...

January 17, 2025 | Friday | News
Eurofins Viracor Launches Groundbreaking Quantitative PCR Assay for Chagas Disease Detection

 Eurofins Viracor, LLC a leading provider of specialty diagnostic testing, and part of the global network of Eurofins companies, is pleased to announc...

January 17, 2025 | Friday | News
Chromatin Bioscience and EsoBiotec Advance First In Vivo BCMA CAR-T Candidate into Clinical Trials

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CA...

January 16, 2025 | Thursday | News
Advanced Genomics APAC Partners with Cancer Precision Medicine to Launch GALEAS™ Bladder Cancer Screening Test in Japan

Advanced Genomics APAC Co., Ltd. (hereinafter referred to as "Advanced Genomics APAC," headquartered in Taiwan, Managing Director: Andy Chang) is pl...

January 15, 2025 | Wednesday | News
Grifols Receives $21 Million Grant from The Michael J. Fox Foundation to Advance Early Detection of Parkinson's Disease

Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a global healthcare company and leading producer of plasma-derived medicines, announced it has received a...

January 15, 2025 | Wednesday | News
AbbVie and Simcere Zaiming Partner to Develop SIM0500 for Relapsed/Refractory Multiple Myeloma

NORTH CHICAGO, Ill. and SHANGHAI, AbbVie (NYSE: ABBV) and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) ann...

January 14, 2025 | Tuesday | News
China Approves Sarclisa for Relapsed/Refractory Multiple Myeloma, Expanding Treatment Options

The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethaso...

January 14, 2025 | Tuesday | News
QIAcuity Digital PCR Expands Capacity to 12 Targets Simultaneously with New Software Update and High Multiplex PCR Kit

  QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold inc...

January 13, 2025 | Monday | News
Samsung Bioepis and Teva Forge Strategic Partnership for U.S. Launch of EPYSQLI® Biosimilar

Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) announced that the companies have entered into a license, developm...

January 13, 2025 | Monday | News
Grifols Submits Biologics License Application for New Fibrinogen Treatment to FDA

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has submitted a B...

January 10, 2025 | Friday | News
Primo Biotechnology Partners with SHINE Technologies to Distribute Ilumira® in Asia-Pacific

Primo Biotechnology (“Primo”) announced a strategic partnership with SHINE Technologies, LLC, (“SHINE”) a global leader in nuclear ...

January 09, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close